FDA.reportPublic FDA data

Thrombomodulin IVD, antibody

Definition
One or multiple immunoglobulins capable of binding to specific antigenic determinants and intended to be used for the qualitative and/or quantitative detection of thrombomodulin in a clinical specimen.
GUDID devices
16
Last updated
2025-03-05 15:17:00

Representative GUDID Devices#

Primary DI, Brand, Company table
Primary DIBrandCompanyModelPublished
B502BSB22790Tinto Thrombomodulin RMabBIO SB, INC.Predilute, 3 ml 2020-06-01
B502BSB22800Tinto Thrombomodulin, RMabBIO SB, INC.Predilute, 7 ml 2020-06-01
B502BSB22810Tinto Thrombomodulin, RMabBIO SB, INC.Predilute, 15 ml 2020-06-01
B502BSB22820Thrombomodulin/ CD141 RMabBIO SB, INC.Concentrate, 0.1 ml 2020-03-16
B502BSB22830Thrombomodulin/ CD141 RMabBIO SB, INC.Concentrate, 0.5 ml 2020-03-16
B502BSB22840Thrombomodulin/ CD141 RMabBIO SB, INC.Concentrate, 1 ml 2020-03-16
00841683137047Thrombomodulin (1009) Mouse Monoclonal AntibodyCELL MARQUE CORPORATION339M-142022-11-14
00841683137054Thrombomodulin (1009) Mouse Monoclonal AntibodyCELL MARQUE CORPORATION339M-152022-11-14
00841683137061Thrombomodulin (1009) Mouse Monoclonal AntibodyCELL MARQUE CORPORATION339M-162022-11-14
00841683137078Thrombomodulin (1009) Mouse Monoclonal AntibodyCELL MARQUE CORPORATION339M-172022-11-14
00841683137085Thrombomodulin (1009) Mouse Monoclonal AntibodyCELL MARQUE CORPORATION339M-182022-11-14
05055331321145Novocastra™LEICA BIOSYSTEMS NEWCASTLE LTDCD141-L-U2021-06-28
05700571101933Mono Mo A-Thrombomodulin Cl 1009AGILENT TECHNOLOGIES, INC.M06172020-09-17
L502BSB2282Thrombomodulin/ CD141 RMabBIO SB, INC.Concentrate, 0.1 ml 2020-03-16
L502BSB2283Thrombomodulin/ CD141 RMabBIO SB, INC.Concentrate, 0.5 ml 2020-03-16
L502BSB2284Thrombomodulin/ CD141 RMabBIO SB, INC.Concentrate, 1 ml 2020-03-16